Preeclampsia discovery could lead to new test and treatments for at-risk pregnancies

Cambridge scientists have identified a key protein that could act as a predictor for preeclampsia and fetal growth restriction, two of the major causes of stillbirth and illness among mothers and newborns. The discovery helps explain why placental cells fail to properly "invade" the uterus in these related conditions and could lead to tests that help identify those at greatest risk and new treatments. The findings are published in Nature Medicine.

Read it at Medical Xpress ↗

← Front page